Abbott Molecular Licenses Affy's CGH Microarray Patents
Affymetrix has licensed a number of patents to Abbott Molecular, a division of Abbott Laboratories, Affy said in a statement last week.
The non-exclusive agreement allows Abbott to manufacture and sell comparative genomic hybridization microarrays, readers, and software for research and diagnostics.
Affymetrix did not disclose details of the license in the statement and declined to comment on the deal. Representatives of Abbott did not return e-mails or phone calls seeking comment.